365 related articles for article (PubMed ID: 18782313)
1. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W
BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
[TBL] [Abstract][Full Text] [Related]
2. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
3. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
Patard JJ; Kim HL; Lam JS; Dorey FJ; Pantuck AJ; Zisman A; Ficarra V; Han KR; Cindolo L; De La Taille A; Tostain J; Artibani W; Dinney CP; Wood CG; Swanson DA; Abbou CC; Lobel B; Mulders PF; Chopin DK; Figlin RA; Belldegrun AS
J Clin Oncol; 2004 Aug; 22(16):3316-22. PubMed ID: 15310775
[TBL] [Abstract][Full Text] [Related]
4. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
5. Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.
Martella O; Galatioto GP; Necozione S; Pomante R; Vicentini C
Arch Ital Urol Androl; 2011 Sep; 83(3):121-7. PubMed ID: 22184835
[TBL] [Abstract][Full Text] [Related]
6. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
[TBL] [Abstract][Full Text] [Related]
8. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma.
Ficarra V; Martignoni G; Lohse C; Novara G; Pea M; Cavalleri S; Artibani W
J Urol; 2006 Apr; 175(4):1235-9. PubMed ID: 16515968
[TBL] [Abstract][Full Text] [Related]
9. [External validation of the University of Los Angeles Integrated Staging System (UISS) in localized renal cell carcinoma: single center study].
Onea C; Mouracade P; Roman H; Wagner B; Saussine C; Jacqmin D; Lang H
Prog Urol; 2010 Jan; 20(1):35-9. PubMed ID: 20123526
[TBL] [Abstract][Full Text] [Related]
10. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
12. Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy.
Cindolo L; Chiodini P; Gallo C; Ficarra V; Schips L; Tostain J; de La Taille A; Artibani W; Patard JJ
Cancer; 2008 Jul; 113(1):65-71. PubMed ID: 18473356
[TBL] [Abstract][Full Text] [Related]
13. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer.
Ramsey S; Lamb GW; Aitchison M; McMillan DC
BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639
[TBL] [Abstract][Full Text] [Related]
15. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
16. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
17. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
18. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
19. Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.
May M; Brookman-Amissah S; Kendel F; Knoll N; Roigas J; Hoschke B; Miller K; Gilfrich C; Pflanz S; Gralla O
Int J Urol; 2009 Jul; 16(7):616-21. PubMed ID: 19456988
[TBL] [Abstract][Full Text] [Related]
20. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
